At 16 she was diagnosed with cancer, at 18 she died because the treatment she needed was too far away

### A Young Life Lost to Cancer Due to the Lack of Access to Treatment

Emily Clark’s journey with cancer began at the tender age of 16 when she was diagnosed with a type of blood cancer. Two years later, at just 18, she tragically passed away because the necessary treatment was not readily available in Wales. Despite being one of the patients with a type of blood cancer that most individuals survive, Emily’s story shed light on the challenges faced within the Welsh healthcare system.

– Emily’s mother, Donna Dunn, recalled the early signs of Emily’s illness, starting with a seemingly innocent complaint about tight jeans at 16.
– Recognizing something was wrong, Emily persisted in seeking medical help, only to face delays and misdiagnosis by doctors.
– After a series of events, Emily was eventually diagnosed with non-Hodgkin lymphoma and underwent intense chemotherapy and a bone marrow transplant.

Despite her valiant fight against the disease, Emily’s treatment was hindered by the lack of specialized care available in Wales. She required treatment in Bristol, which proved too far for her to travel due to her deteriorating condition. This lack of access to vital treatment ultimately led to Emily’s untimely death at 18.

### Raising Awareness and Seeking Improvements

After Emily’s passing, Donna and her family became strong advocates for raising awareness about blood cancer symptoms and advocating for better treatments. They have pledged their support to Blood Cancer UK’s Action Plan, which aims to improve workforce support, early diagnosis initiatives, and access to treatments.

– Blood Cancer UK has identified challenges within the Welsh healthcare system, highlighting critical staff shortages and the need for increased support for blood cancer patients.
– Dr. Ceri Bygrave emphasized the pressing need to address staffing shortages and infrastructure limitations in Wales to enhance blood cancer care.

### A Legacy of Advocacy

Emily’s legacy lives on through her family’s tireless efforts to improve blood cancer care in Wales. Their advocacy aims to prevent other families from enduring similar hardships and emphasizes the importance of timely access to specialized treatments for all patients.

– Donna Dunn’s commitment to continuing Emily’s legacy underscores the urgent need for enhanced support and resources for individuals battling blood cancer in Wales.
– The Welsh Government acknowledges the challenges within the healthcare system and pledges ongoing investments to bolster cancer services and address workforce shortages.

Through Emily’s story, a poignant narrative emerges, highlighting the critical need for improved access to specialized treatments for individuals facing life-threatening illnesses. The legacy of advocacy left by Emily and her family serves as a powerful reminder of the ongoing fight for better healthcare services and support for all those affected by cancer.